These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

225 related items for PubMed ID: 2591151

  • 21. Effect of desmopressin acetate on bleeding times and plasma von Willebrand factor in Doberman pinscher dogs with von Willebrand's disease.
    Kraus KH, Turrentine MA, Jergens AE, Johnson GS.
    Vet Surg; 1989; 18(2):103-9. PubMed ID: 2786279
    [Abstract] [Full Text] [Related]

  • 22. Type IIB von Willebrand's disease: differential clearance of endogenous versus transfused large multimer von willebrand factor.
    Ruggeri ZM, Lombardi R, Gatti L, Bader R, Valsecchi C, Zimmerman TS.
    Blood; 1982 Dec; 60(6):1453-6. PubMed ID: 6982737
    [Abstract] [Full Text] [Related]

  • 23. Platelet--von Willebrand factor interactions in type IIB von Willebrand's disease.
    Holmberg L, Kristoffersson AC, Lamme S, Nilsson IM, Awidi A, Solum NO.
    Scand J Haematol; 1985 Sep; 35(3):305-14. PubMed ID: 3877338
    [Abstract] [Full Text] [Related]

  • 24. Studies of the pathophysiology of acquired von Willebrand's disease in seven patients with lymphoproliferative disorders or benign monoclonal gammopathies.
    Mannucci PM, Lombardi R, Bader R, Horellou MH, Finazzi G, Besana C, Conard J, Samama M.
    Blood; 1984 Sep; 64(3):614-21. PubMed ID: 6432075
    [Abstract] [Full Text] [Related]

  • 25. Response of von Willebrand factor parameters to desmopressin in patients with type 1 and type 2 congenital von Willebrand disease: diagnostic and therapeutic implications.
    Michiels JJ, van de Velde A, van Vliet HH, van der Planken M, Schroyens W, Berneman Z.
    Semin Thromb Hemost; 2002 Apr; 28(2):111-32. PubMed ID: 11992235
    [Abstract] [Full Text] [Related]

  • 26. Desmopressin enhances the binding of plasma von Willebrand factor to collagen in plasmas from normal dogs and dogs with type I von Willebrand's disease.
    Johnstone IB.
    Can Vet J; 1999 Sep; 40(9):645-8. PubMed ID: 10495907
    [Abstract] [Full Text] [Related]

  • 27.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 28.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 29. The effects of desmopressin on plasma factor VIII/von Willebrand factor activity in dogs with von Willebrand's disease.
    Johnstone IB, Crane S.
    Can J Vet Res; 1987 Apr; 51(2):189-93. PubMed ID: 3111674
    [Abstract] [Full Text] [Related]

  • 30.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 31.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 32. Dominant von Willebrand disease type 2A groups I and II due to missense mutations in the A2 domain of the von Willebrand factor gene: diagnosis and management.
    Michiels JJ, van Vliet HH.
    Acta Haematol; 2009 Apr; 121(2-3):154-66. PubMed ID: 19506362
    [Abstract] [Full Text] [Related]

  • 33. A new candidate mutation, G1629R, in a patient with type 2A von Willebrand's disease: basic mechanisms and clinical implications.
    Hilbert L, Federici AB, Baronciani L, Dallagiovanna S, Mazurier C.
    Haematologica; 2004 Sep; 89(9):1128-33. PubMed ID: 15377475
    [Abstract] [Full Text] [Related]

  • 34. Dominant von Willebrand disease type 2M and 2U are variable expressions of one distinct disease entity caused by loss-of-function mutations in the A1 domain of the von Willebrand factor gene.
    Gadisseur A, van der Planken M, Schroyens W, Berneman Z, Michiels JJ.
    Acta Haematol; 2009 Sep; 121(2-3):145-53. PubMed ID: 19506361
    [Abstract] [Full Text] [Related]

  • 35. Laboratory diagnosis and molecular classification of von Willebrand disease.
    Gadisseur A, Hermans C, Berneman Z, Schroyens W, Deckmyn H, Michiels JJ.
    Acta Haematol; 2009 Sep; 121(2-3):71-84. PubMed ID: 19506352
    [Abstract] [Full Text] [Related]

  • 36. Von Willebrand's disease: case report and review of literature.
    Echahdi H, El Hasbaoui B, El Khorassani M, Agadr A, Khattab M.
    Pan Afr Med J; 2017 Sep; 27():147. PubMed ID: 28904675
    [Abstract] [Full Text] [Related]

  • 37. Combined haemophilia A and type I von Willebrand's disease: a family study including an evaluation of the effects of DDAVP infusion.
    Casonato A, Pontara E, Boscaro M, Dannhauser D, Sartori MT, Girolami A.
    Haematologia (Budap); 1993 Sep; 25(1):57-67. PubMed ID: 8339998
    [Abstract] [Full Text] [Related]

  • 38.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 39. Response to DDAVP in children with von Willebrand disease type 2.
    Schneppenheim R, Budde U, Beutel K, Hassenpflug WA, Hauch H, Obser T, Oyen F, Schneppenheim S, Schrum J.
    Hamostaseologie; 2009 May; 29(2):143-8. PubMed ID: 19404524
    [Abstract] [Full Text] [Related]

  • 40.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 12.